ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 748

Takayasu Arteritis and Sacroiliitis: A Case Control Study in 28 Patients of a Single Italian Center

Paola Toniati1, Francesca Regola 1, Franco Franceschini 1, Giovanni Bosio 2 and Angela Tincani 3, 1Rheumatology and Clinical Immunology Unit, ASST Spedali Civili and University of Brescia, Brescia, Italy, Brescia, Italy, 2Nuclear Medicine Unit, ASST Spedali Civili of Brescia, Brescia, Italy, Brescia, Italy, 3Rheumatology and Clinical Immunology, Spedali Civili and Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy, Brescia, Italy

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: axial spondyloarthritis, large vessel vasculitis and sacroiliitis, Takayasu arteritis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 10, 2019

Title: Vasculitis – Non-ANCA-Associated & Related Disorders Poster I: Takayasu's Arteritis & Polymyalgia Rheumatica

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: A lot of clinical case descriptions about spondyloarthropathy in TAK patients were reported. Recently, a paper about an increased incidence of spondyloarthropathy in TAK patients (Guzel Esen S., Joint Bone Spine 2019 in press) was published. The diagnosis of sacroiliitis may be performed by X-ray, CT or MRI. CT findings of sacroiliitis are: contour irregularities, joint space alterations, joint erosion, subcondral bone changes (osteoporosis or sclerosis), enthesitis, ankylosis. Patients with Takayasu Arteritis (TAK) performe routinely  FDG-CT-PET for monitoring disease activity. 
The aim of this study is to understand if there are an increased association of sacroiliitis in TAK patients in our monocentric cohort.

Methods: We collected retrospectively imaging data (CT) from 28 patients affected by TAK and 28 controls undergoing FDG-PET-CT scan in our center. Controls were selected among patients who performed FDG-PET-CT in our Nuclear Medicine Unit, excluding patients with bone tumors, tumors with bone metastasis and thyroid cancers. The majority of controls were affected by lymphoma in a complete remission. Controls and patients were matched for sex and age. An expert rheumatologist read the CT scans of sacroiliac joints.

Results: No patients and no controls demonstrated FDG-uptake in sacroiliac joints.

In the control group, we detected sacroiliac sclerosis in two cases: one due to a degenerative changes and another to a sacroiliitis (1/28, 4%).

In the TAK group four patients presented CT alterations suggestive for sacroiliitis: bilateral erosions in one case, a bilateral sclerosis in one case, a mono lateral sclerosis in two cases (4/28,14%). One of these patients complained an inflammatory back pain.

Conclusion: In our cohort of TAK  patients we demonstrated an increased prevalence of  sacroiliitis, diagnosed by CT scan. Only one patient of TAK group reported an inflammatory back pain, while three patients had only radiological signs of  previous sacroiliitis. This reinforce the need to look for spondyloarthropathy in TAK patients even if asymptomatic. 


Disclosure: P. Toniati, None; F. Regola, None; F. Franceschini, None; G. Bosio, None; A. Tincani, None.

To cite this abstract in AMA style:

Toniati P, Regola F, Franceschini F, Bosio G, Tincani A. Takayasu Arteritis and Sacroiliitis: A Case Control Study in 28 Patients of a Single Italian Center [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/takayasu-arteritis-and-sacroiliitis-a-case-control-study-in-28-patients-of-a-single-italian-center/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/takayasu-arteritis-and-sacroiliitis-a-case-control-study-in-28-patients-of-a-single-italian-center/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology